Kinnate Biopharma Inc.

CIK 1797768 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kinnate Biopharma Inc..

Recent SEC filings

FiledFormAccession number
Nov 13, 2024SC 13G/A0001193125-24-257099
Apr 17, 202415-12G0001193125-24-099060
Apr 5, 202440001415889-24-010426
Apr 5, 202440000947871-24-000354
Apr 5, 202440001415889-24-010433
Apr 5, 202440001415889-24-010429
Apr 5, 202440001415889-24-010430
Apr 5, 202440001415889-24-010431
Apr 5, 202440000947871-24-000353
Apr 5, 202440001415889-24-010432
Apr 5, 2024SC 13D/A0000950142-24-000986
Apr 5, 202440001415889-24-010425
Apr 5, 202440001415889-24-010428
Apr 5, 202440001415889-24-010427
Apr 5, 202440001415889-24-010434
Apr 5, 202440001415889-24-010424
Apr 5, 202440001104659-24-044187
Apr 3, 2024SC TO-T/A0001193125-24-085519
Apr 3, 2024S-8 POS0001193125-24-086133
Apr 3, 2024POSASR0001193125-24-086117
Apr 3, 202425-NSE0001354457-24-000225
Apr 3, 2024S-8 POS0001193125-24-086126
Apr 3, 2024S-8 POS0001193125-24-086130
Apr 3, 2024SC 14D9/A0001193125-24-085521
Apr 3, 20248-K0001193125-24-085548